Mechanism of Action
Glucagon-like Peptide-1 (GLP-1) Agonists
GLP-1 Receptor Agonist
Clinical Trials (5)
Examination of How the Duration of Fasting and Temporary Stopping of GLP-1 Medications Affect the Amount of Food Left in the Stomach in People Using Liraglutide (Injected), Semaglutide (Taken by Mouth) or Semaglutide (Injected)
Study to Evaluate the Safety and Effectiveness of Saxenda® for Weight Management in Routine Clinical Practice in Taiwan.
INSPIRE Turkey :A Research Study Looking at the Clinical Parameters Associated With Use and Discontinuation of Saxenda® in Local Clinical Practice in Turkey by Analysing Past Patient Medical Records
A Research Study Looking at Blood Sugar Control in People With Type 2 Diabetes Previously Treated With Premix Insulin and Initiating Treatment With Insulin Degludec/Liraglutide (IDegLira) in Local Clinical Practice in Croatia
Efficacy of Liraglutide Therapy in Patients With IPAA
Loss of Exclusivity
Patent Records (4)
| Patent # | Expiry | Type | Use Code |
|---|---|---|---|
| 8114833 | Aug 13, 2025Expired | Product | — |
| 8114833*PED | Feb 13, 2026Expired | — | |
| 9968659 | Jan 9, 2037 | U-2438 | |
| 9968659*PED | Jul 9, 2037 | — |